Intravenous Immunoglobulin and Rituximab Most Effective EBA Treatments, Study Reports
News
Treatment with intravenous immunoglobulin (IVIG) and off-label rituximab can lead to complete remission of epidermolysis bullosa acquisita (EBA), according to a study that also illustrates the variable clinical and immunological presentations ... Read more